NOVO NORDISK A S
Develops innovative medicines for diabetes, obesity, and rare blood & endocrine disorders.
NVO | NYSE
Overview
Corporate Details
- ISIN(s):
- DK0060534915
- LEI:
- Country:
- United States of America
- Address:
- NOVO ALLE DK 2880, 0 BAGSVAERD DENMARK
- Website:
- https://www.novonordisk.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Novo Nordisk A/S is a leading global healthcare company, founded in 1923, dedicated to defeating serious chronic diseases. The company focuses on discovering, developing, manufacturing, and marketing innovative biological medicines and medical devices. Its primary therapeutic areas include diabetes care, obesity management, and the treatment of rare blood and endocrine disorders. With a history of over a century in innovation, Novo Nordisk provides treatments and care solutions to patients worldwide, aiming to drive change and improve health outcomes for people living with long-term conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all NOVO NORDISK A S filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NOVO NORDISK A S
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NOVO NORDISK A S via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
